Antivirals for herpes simplex viruses

@article{Sawleshwarkar2015AntiviralsFH,
  title={Antivirals for herpes simplex viruses},
  author={Shailendra Sawleshwarkar and Dominic E. Dwyer},
  journal={BMJ : British Medical Journal},
  year={2015},
  volume={351}
}
#### The bottom line A 25 year old woman presents to her general practitioner with a two day history of painful vulval lesions. She has not had previous episodes and does not have any significant previous medical history. She is in a new relationship with a male partner. Genital examination shows multiple vulval ulcers. Herpes simplex viruses type 1 and type 2 (HSV-1 and HSV-2) commonly cause mucocutaneous disease, including orolabial infections (more commonly HSV-1; for example… 
View on BMJ
learning.bmj.com
6 Citations
Background Citations
2

6 Citations

Citation Type

Citation Type

MANAGEMENT OF HSV-1 AND HSV-2 PRIMARY INFECTION IN ADULT PATIENT: A CASE REPORT
TLDR
Correct diagnosis and treatment can restore well-being, avoid secondary problems for patients, and prevent the use of inappropriate drugs.
ANTIVIRAL DRUG REVIEW A GUIDE TO CLINICIANS
TLDR
The aim of this review is to present the antiviral drugs currently available, focusing on treatment of common viral infections in clinical practice, using the data available from evidence-based medicine.
Anti-herpes simplex type-1 (HSV-1) activity from the roots of Jatropha multifida L
A new long chain, multifidione (1), together with seven known lathyrane-type diterpenes, 15-epi-4Z-jatrogrossidentadion (2), 4Z-jatrogrossidentadion (3), 2-epi-hydroxy isojatrogrossidentadion (4),…
Anti-herpes simplex virus activities of monogalactosyl diglyceride and digalactosyl diglyceride from Clinacanthus nutans, a traditional Thai herbal medicine
Modern Aspects of Herpetic Infection with Manifestations in the Oral Cavity
TLDR
This document is intended to help clarify the role of acronyms in the history of this type of document.
Centre for Infectious Diseases and Microbiology - Annual Report 2015

References

SHOWING 1-10 OF 22 REFERENCES
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
TLDR
In placebo-controlled trials, there was a low quality evidence that the risk of having at least one clinical recurrence was reduced with acyclovir, and in parallel-group trials by daily dose, no clear evidence was found of a dose-response relationship for any drug.
Once-daily valacyclovir to reduce the risk of transmission of genital herpes*
TLDR
Once-daily suppressive therapy with valacyclovir significantly reduces the risk of transmission of genital herpes among heterosexual, HSV-2-discordant couples.
[Genital herpes].
  • T. Kawana
  • Medicine
    Nihon rinsho. Japanese journal of clinical medicine
  • 2009
TLDR
For rapid diagnosis of GH, LAMP(loop-mediated isothermal amplification), HSV DNA nuclear amplification method developed in Japan, was applied and favorable results were obtained and Platteria was shown to be most sensitive and specific.
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
TLDR
The management algorithm presented herein uses both serological and virological studies to determine the risk of HSV transmission to the neonate who is delivered to a mother with active herpetic genital lesions and tailors management accordingly.
Efficacy results of a trial of a herpes simplex vaccine.
TLDR
In a study population that was representative of the general population of HSV-1- and HSv-2-seronegative women, the investigational vaccine was effective in preventing HSV -1 genital disease and infection but not in preventingHSV-2 disease or infection.
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
TLDR
The gold standard phenotypic method for evaluating the susceptibility of HSV isolates to antiviral drugs is the plaque reduction assay and there is a need to develop new antiherpetic compounds with different mechanisms of action.
Clinical and Virologic Response to Episodic Acyclovir for Genital Ulcers Among HIV-1 Seronegative, Herpes Simplex Virus Type 2 Seropositive African Women: A Randomized, Placebo-Controlled Trial
TLDR
In a randomized trial among African women with recurrent genital herpes, episodic acyclovir therapy resulted in modestly greater likelihood of lesion healing and cessation of herpes simplex virus shedding compared with placebo.
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
TLDR
Infants surviving neonatal HSV disease with CNS involvement had improved neurodevelopmental outcomes when they received suppressive therapy with oral acyclovir for 6 months.
Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
TLDR
Suppressive treatment with 0.5 g of valacyclovir twice daily was not shown to prohibit recurrent meningitis and cannot be recommended for this purpose after HSVMeningitis in general.
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
TLDR
There is evidence that aciclovir is efficacious in the prevention and treatment of herpes simplex virus infections, but there is no evidence that valaciclovIR is more efficacious than acic Lovir, or that higher doses of valacallovir are more effective than lower doses.
...
1
2
3
...